Reimund M, Dearborn A, Graziano G, Lei H, Ciancone A, Kumar A
Nature. 2024; 638(8051):829-835.
PMID: 39663455
DOI: 10.1038/s41586-024-08223-0.
Rodriguez-Jimenez C, de la Pena G, Sanguino J, Poyatos-Pelaez S, Carazo A, Martinez-Hernandez P
Int J Mol Sci. 2023; 24(8).
PMID: 37108800
PMC: 10142790.
DOI: 10.3390/ijms24087635.
Vaseghi G, Malakoutikhah Z, Shafiee Z, Gharipour M, Shariati L, Sadeghian L
J Res Med Sci. 2021; 26:94.
PMID: 34899932
PMC: 8607183.
DOI: 10.4103/jrms.JRMS_970_19.
Futema M, Taylor-Beadling A, Williams M, Humphries S
J Lipid Res. 2021; 62:100139.
PMID: 34666015
PMC: 8572866.
DOI: 10.1016/j.jlr.2021.100139.
Kamar A, Khalil A, Nemer G
Front Genet. 2021; 11:572045.
PMID: 33519890
PMC: 7844333.
DOI: 10.3389/fgene.2020.572045.
Targeted Genetic Analysis in a Chinese Cohort of 208 Patients Related to Familial Hypercholesterolemia.
Wang H, Yang H, Liu Z, Cui K, Zhang Y, Zhang Y
J Atheroscler Thromb. 2020; 27(12):1288-1298.
PMID: 32759540
PMC: 7840166.
DOI: 10.5551/jat.54593.
Dyslipidemia: Genetics, lipoprotein lipase and HindIII polymorphism.
Palacio Rojas M, Prieto C, Bermudez V, Garicano C, Nunez Nava T, Martinez M
F1000Res. 2018; 6:2073.
PMID: 30345000
PMC: 6171722.
DOI: 10.12688/f1000research.12938.2.
Mutation detection in Chinese patients with familial hypercholesterolemia.
Du R, Fan L, Lin M, He Z, Huang H, Chen Y
Springerplus. 2016; 5(1):2095.
PMID: 28028493
PMC: 5153400.
DOI: 10.1186/s40064-016-3763-3.
Global molecular analysis and APOE mutations in a cohort of autosomal dominant hypercholesterolemia patients in France.
Wintjens R, Bozon D, Belabbas K, MBou F, Girardet J, Tounian P
J Lipid Res. 2016; 57(3):482-91.
PMID: 26802169
PMC: 4766997.
DOI: 10.1194/jlr.P055699.
Structural analysis of APOB variants, p.(Arg3527Gln), p.(Arg1164Thr) and p.(Gln4494del), causing Familial Hypercholesterolaemia provides novel insights into variant pathogenicity.
Fernandez-Higuero J, Etxebarria A, Benito-Vicente A, Alves A, Arrondo J, Ostolaza H
Sci Rep. 2015; 5:18184.
PMID: 26643808
PMC: 4672294.
DOI: 10.1038/srep18184.
Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population.
Radovica-Spalvina I, Latkovskis G, Silamikelis I, Fridmanis D, Elbere I, Ventins K
BMC Med Genet. 2015; 16:86.
PMID: 26415676
PMC: 4587402.
DOI: 10.1186/s12881-015-0230-x.
The implications of familial incidental findings from exome sequencing: the NIH Undiagnosed Diseases Program experience.
Lawrence L, Sincan M, Markello T, Adams D, Gill F, Godfrey R
Genet Med. 2014; 16(10):741-50.
PMID: 24784157
PMC: 4190001.
DOI: 10.1038/gim.2014.29.
Identification and biochemical analysis of a novel APOB mutation that causes autosomal dominant hypercholesterolemia.
Thomas E, Atanur S, Norsworthy P, Encheva V, Snijders A, Game L
Mol Genet Genomic Med. 2014; 1(3):155-61.
PMID: 24498611
PMC: 3865582.
DOI: 10.1002/mgg3.17.
The genetic basis of familial hypercholesterolemia: inheritance, linkage, and mutations.
De Castro-Oros I, Pocovi M, Civeira F
Appl Clin Genet. 2013; 3:53-64.
PMID: 23776352
PMC: 3681164.
DOI: 10.2147/tacg.s8285.
Genetic variants associated with VLDL, LDL and HDL particle size differ with race/ethnicity.
Frazier-Wood A, Manichaikul A, Aslibekyan S, Borecki I, Goff D, Hopkins P
Hum Genet. 2012; 132(4):405-13.
PMID: 23263444
PMC: 3600091.
DOI: 10.1007/s00439-012-1256-1.
Molecular characterization of Iranian patients with possible familial hypercholesterolemia.
Farrokhi E, Shayesteh F, Asadi Mobarakeh S, Roghani Dehkordi F, Samani K, Hashemzadeh Chaleshtori M
Indian J Clin Biochem. 2012; 26(3):244-8.
PMID: 22754187
PMC: 3162949.
DOI: 10.1007/s12291-011-0113-7.
Mipomersen: evidence-based review of its potential in the treatment of homozygous and severe heterozygous familial hypercholesterolemia.
Parhofer K
Core Evid. 2012; 7:29-38.
PMID: 22701100
PMC: 3373191.
DOI: 10.2147/CE.S25239.
Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia.
Johansen C, Wang J, Lanktree M, Cao H, McIntyre A, Ban M
Nat Genet. 2010; 42(8):684-7.
PMID: 20657596
PMC: 3017369.
DOI: 10.1038/ng.628.
Molecular characterization of Polish patients with familial hypercholesterolemia: novel and recurrent LDLR mutations.
Chmara M, Wasag B, Zuk M, Kubalska J, Wegrzyn A, Bednarska-Makaruk M
J Appl Genet. 2010; 51(1):95-106.
PMID: 20145306
DOI: 10.1007/BF03195716.
Common and rare gene variants affecting plasma LDL cholesterol.
Burnett J, Hooper A
Clin Biochem Rev. 2008; 29(1):11-26.
PMID: 18566665
PMC: 2423314.